Group 1: Financial Performance - In 2024, the company achieved a revenue of CNY 1.658 billion, a year-on-year increase of 12.42% [3] - The net profit attributable to shareholders for 2024 was CNY 77.5885 million, a year-on-year decrease of 11.70% [3] - In Q1 2025, the company reported a revenue of CNY 388 million, remaining stable compared to the same period last year [3] - The net profit attributable to shareholders in Q1 2025 was CNY 18.1368 million, a year-on-year increase of 47.12% [3] - The net profit excluding non-recurring items for Q1 2025 was CNY 18.048 million, a year-on-year increase of 75.04% [3] Group 2: Product Development and Market Strategy - The company has developed and promoted high-performance polyurethane new materials, resulting in a sales volume increase of 24.72% in 2024 [3] - The company is focusing on optimizing the sales structure of its polyurethane products, with a higher proportion of specialty products contributing to improved profit margins [4] - The company plans to quickly enter markets for short verification cycle fields such as adhesives and coatings, while preparing for longer verification cycles with larger manufacturers [5] - The company is advancing the construction of two projects: a TPU project with an annual capacity of 10,000 tons and a water-based polyurethane project with an annual capacity of 30,000 tons, both expected to be completed by late 2025 or early 2026 [6][7] Group 3: Supply Chain and Cost Management - The company has optimized its supply chain structure, leading to reduced raw material procurement costs and improved product profitability [4] - The company’s export business to the U.S. accounts for less than 1% of total revenue, indicating limited direct impact from U.S. tariff policies [5] Group 4: Future Outlook and Strategic Initiatives - The company aims to enhance its competitive advantage through R&D innovation, focusing on functional chemical raw materials and polyurethane new materials [8] - The company is committed to expanding emerging application scenarios and improving service capabilities to mitigate risks from market fluctuations [9] - The company plans to utilize a simplified procedure for issuing stocks, with a maximum fundraising limit of CNY 300 million, not exceeding 20% of the net assets at the end of the previous year [9]

证券代码：835438 证券简称：戈碧迦 公告编号：2025-059 湖北戈碧迦光电科技股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 活动时间：2025 年 4 月 21 日 15:00-16:00 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 二、 投资者关系活动情况 活动地点：湖北戈碧迦光电科技股份有限公司（以下简称"公司"）于 2025 年 4 月 21 日（星期一）15:00-16:00 在全景网"投资者关系互动平台" （https://ir.p5w.net）采用网络远程的方式召开 2024 年年度报告业绩说明会。 参会单位及人员：通过网络方式参加公司 2024 年年度报告业绩说明会的投 资者 上市公司接待人员：公司董事长：吴林海先生；公司财务负责人：李金蓉女 士；公司证券事务代表：张力先生；公司保荐代表人：童宏杰先生。 三、 投资者关系活动主要内容 本次业绩说明会公司通过网络 ...

| 司能给予投资者更多的信心。谢谢 | | --- | | 答:投资者您好！ | | 一、公司一季度营收稳定，利润下滑主要是公司整体毛 | | 利率下降、研发投入增加导致，其中毛利率下降的原因如 | | 下： | | 1、内部因素：客户结构、产品结构发生了一定变化，部 | | 分高毛利率的产品即将结束生命周期，新项目尚在爬坡期， | | 从而导致整体毛利率降低； | | 2、外部因素：部分客户预测美方关税政策不乐观，调整 | | 了对美的出货节奏，在2024年第四季度加大出货量，导致公 | | 司2024年第四季度的营收和利润同比均有较大增长，从而影 | | 响了2025年第一季度的出货量，进而影响了第一季度的利润 | | 水平； | | 3、2025年起，公司应客户要求将部分量产项目转移到马 | | 来西亚工厂生产，该转移会产生额外费用支出，以及短期马 | | 来西亚工厂的生产效率不及预期，进而导致毛利率的下降。 | | 而研发投入增加的原因为公司进入新的产业链和产品升 | | 级，需要加大对新技术和新产品的研发投入。 | | 二、公司对美出口方面，2023年销售占比为23.05%， | | 2024年销售 ...

Group 1: Company Performance Overview - In 2024, the company achieved operating revenue of 287,163.57 million yuan, a decrease of 36.92% year-on-year, primarily due to a 54.22% contraction in the smart energy and environmental management system business [3] - The overall gross margin for other business segments was 34.25%, an increase of 3.30 percentage points year-on-year [3] - The product business scale increased by 15.62 percentage points year-on-year, contributing 93.12% to gross profit, which is a 47.71% increase year-on-year [3] Group 2: Q1 2025 Business Performance - In Q1 2025, the smart energy and environmental management system revenue dropped by over 90%, while other business revenues grew by over 23%, with a comprehensive gross margin of 37.43% [3] - The product business revenue increased by 8.87% year-on-year, with industrial robot revenue rising by 23.81% [3] - The company received over 120 orders for CNC machine tools, with order value increasing by over 70% [3] Group 3: Industrial Robot Business - In 2024, the industrial robot segment generated revenue of 27,531.64 million yuan, reflecting a 12.50% year-on-year growth, with a gross margin of 47.53%, up by 3.93 percentage points [4] - The growth was driven by a 26.20% increase in revenue from coordinate robots due to heightened demand in the injection molding industry [4] - The company reduced low-margin trading robot business while rapidly expanding its self-produced multi-joint robot business, achieving a shipment of over 2,000 units, with a revenue increase of 76.04% [4] Group 4: CNC Machine Tool Business - In 2024, the CNC machine tool segment reported revenue of 30,816.43 million yuan, with a gross margin of 29.85%, experiencing an 11.71% decline due to production constraints from capacity relocation [5] - Approximately 270 units of five-axis CNC machine tools were sold, with over 250 units shipped [5] Group 5: Injection Molding Equipment Business - In 2024, the injection molding machine and related equipment segment achieved revenue of 51,121.47 million yuan, an 18.67% increase year-on-year, with a gross margin of 32.75% [6] - The injection molding machine revenue rose by 10.50%, with order volume increasing by approximately 150% and shipment volume growing by over 300% [6] Group 6: Embodied Intelligence Development - The company is focusing on embodied intelligence by launching a new generation of intelligent robot control platform, which integrates sensing, computing, and control [7] - Collaborations with major cloud service providers like Huawei Cloud and Alibaba Cloud are underway to explore embodied intelligence applications [8] - The company aims to develop intelligent robots tailored to real customer scenarios, addressing pain points in manufacturing [8]

| | 1、请介绍公司目前的产能情况？ | | --- | --- | | | 截至2025年一季度末，公司产能如下：钴产品2.65万金属 | | | 吨、镍产品1万金属吨、锰产品1万金属吨、碳酸锂0.5万吨，铜 | | | 产品6万吨。 | | | 2、请问2024年公司钴产品产销结构是什么样？ | | | 公司钴相关产线均为柔性化设计，可根据市场需求的变化灵 | | | 活调整各产品产量。2024年整体来看，消费电子市场回暖信号明 | | | 显，公司钴产品中氯化钴占比约50%，硫酸钴占比近40%，电钴基 | | | 本是满产的状态。 | | | 3、请问2025年一季度公司营收净利润同比下降原因？ | | | 公司2025年一季度净利润同比下降原因主要系刚果腾远受电 | | 投资者关系活 | 力紧缺影响，导致铜产品产能未能充分释放。在电力保障方面， | | 动主要内容介 | 公司将积极推进刚果腾远四期项目建设进度，同时柴油发电项目 | | 绍 | 也将在二季度投入使用，补充生产用电，充分释放既定产能。 | | | 4、请问公司一季报中合同负债大幅增长，是什么原因？ | | | 公司2025年一季度合同负 ...

编号：2025-004 | | □特定对象调研 □分析师会议 | | --- | --- | | 投资者关系 | □媒体采访 □业绩说明会 | | 活动类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | 其他 （电话会议）  | | | 上午 9:00 场：东方财富、华泰证券、复通私募投资基金、招商证券股份有限 | | | 公司、中邮证券有限责任公司、青岛羽田私募基金管理有限公司、深圳市四 | | | 海圆通投资有限公司、华杉投资、北京同巨投资有限公司、领颐(上海)资产 | | | 管理有限公司、深圳中天汇富基金管理有限公司、青岛中航赛维投资有限公 | | | 司、中银理财有限责任公司、中信证券（资管）、华夏久盈资产管理有限责 | | | 任公司、上海浩瑜恒投资管理有限公司、上海盟洋投资管理有限公司、中再 | | | 资产管理股份有限公司、杭州长谋投资管理有限公司、全天候私募证券基金 | | 参与单位名 | 投资管理(珠海)合伙企业(有限合伙)、粤佛私募基金管理(武汉)有限公司、中 | | | 信建投基金、上海天猊投资、米仓资本、北京星允投资管理有限公司 | | 称及人员姓 | | | ...

Group 1: Company Performance Overview - In 2024, the company sold 516 million yellow feathered chickens, a year-on-year increase of 12.95% [2] - The company sold 1.298 million pigs, a year-on-year increase of 51.8% [2] - The company sold 2.0963 million geese, a year-on-year increase of 21.73% [2] - The total operating revenue for 2024 was 17.725 billion yuan, a year-on-year increase of 15.44% [2] - The net profit attributable to shareholders was 1.521 billion yuan, marking a significant turnaround from losses [2] - In Q1 2025, the company sold 123 million chickens, a year-on-year increase of 8.69% [2] - The company sold 483,700 pigs in Q1 2025, a year-on-year increase of 150.49% [2] - The net profit attributable to shareholders in Q1 2025 was 206 million yuan, a year-on-year increase of 157.47% [2] Group 2: Cost and Production Insights - The complete cost of chicken in 2024 was 5.9 yuan per kilogram, reduced to 5.5 yuan in Q1 2025 [3] - The company aims for an annual growth target of 8%-10% in yellow feathered chicken output [4] - The target for pig output in 2025 is 2 million heads, with a complete cost of 6.4 yuan per kilogram [4] - The company has established a slaughter capacity of 120 million chickens, with a target of 100 million for 2025 [5] Group 3: Research and Development - In 2024, the company invested 140 million yuan in R&D, primarily for breeding improvements [6] - The company has set up four breeding bases and a genomic breeding laboratory to enhance chicken breeding technology [6] - The breeding team consists of professionals with advanced degrees, focusing on improving breeding quality and biosecurity [6] Group 4: Market Outlook - The company is optimistic about the future of the yellow feathered chicken market, despite cyclical fluctuations [7] - From 2022 to 2024, the cumulative net profit reached nearly 2 billion yuan, with an average revenue growth rate of 42% [8]

证券代码：300342 证券简称：天银机电 常熟市天银机电股份有限公司 投资者关系活动记录表 编号：2025-01 | 投资者关系活动 | □特定对象调研 □分析师会议 | | --- | --- | | 类别 | □媒体采访 业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 | | 参与单位名称及 | 线上参与天银机电2024年度业绩网上说明会的投资者 | | 人员姓名 | | | 时间 | 2025年4月22日 下午15:00至17:00 | | 地点 | 价值在线（www.ir-online.cn）网络互动 | | 上市公司接待人 | 董事、总经理：赵云文先生 | | 员姓名 | 独立董事：李灵辉先生 | | | 副总经理、董事会秘书：方程先生 | | | 副总经理、财务总监：李荟女士 | | | 本次年度业绩说明会不涉及应披露的重大信息。 | | | 公司就投资者在本次说明会中提出的主要问题进行了回复： | | | 1、请问公司双总部战略规划进展情况如何？ | | | 答：您好，上市公司推动"常熟+南海"双总部战略。其 | | | 中常熟总部将继续深化"冰 ...

Financial Performance - In 2024, the company achieved operating revenue of CNY 444,312.36 million, a year-on-year increase of 9.47% [2][3] - Total profit reached CNY 39,526.12 million, up 59.02% year-on-year, with net profit attributable to the parent company at CNY 32,629.10 million, a 14.73% increase [3] - Overseas revenue amounted to CNY 186,513.93 million, accounting for 41.98% of total revenue [3] Business Strategy and Market Expansion - The company focuses on blood glucose monitoring products as its core business, emphasizing technological innovation and cost reduction to enhance operational efficiency [2][4] - The company is expanding into Southeast Asia and other developing markets to seize new opportunities [2][4] - A partnership with A. MENARINI DIAGNOSTICS S.r.l. was established for exclusive distribution in over 20 European countries [5] Product Development and Regulatory Progress - The self-developed Continuous Glucose Monitoring (CGM) system entered the substantive review phase of FDA 510(k) registration in December 2024 [7] - The company is actively exploring AI applications in diabetes management, aiming to create a closed-loop system for smart diabetes management [17] Sales and Marketing Insights - In 2024, the company’s sales expenses increased by 21.53% to CNY 119,177.46 million, driven by online sales and CGM product marketing [14] - The blood glucose monitoring system product revenue grew by 15.58% year-on-year, with a gross margin increase of 1.11% [14][15] Challenges and Risk Management - The company reported asset impairment losses exceeding CNY 74 million, primarily due to inventory and long-term equity investments [11] - The impact of US-China tariff policies on business operations is considered manageable, with 31.06% of revenue derived from the US market [8][9] Future Goals - The company aims to achieve operating revenue of CNY 49 billion in 2025, focusing on professionalization, digitalization, and globalization [16]

证券代码：300221 证券简称：银禧科技 广东银禧科技股份有限公司 投资者关系活动记录表 编号：2025-3 投资者关系活动 类别 □特定对象调研 □ 分析师会议 □ 媒体采访 √ 业绩说明会 □ 新闻发布会 □ 路演活动 □ 现场参观 □ 其他 （请文字说明其他活动内容） 参与单位名称及 人员姓名 投资者网上提问 时间 2025 年 4 月 22 日 (周二) 下午 15:00~17:00 地点 公司通过全景网"投资者关系互动平台" （https://ir.p5w.net）采用网络远程的方式召开业绩说明 会 上市公司接待人 员姓名 1、董事长谭文钊 2、总经理林登灿 3、董秘郑桂华 4、财务总监顾险峰 5、独立董事赵建青 投资者关系活动 主要内容介绍 投资者提出的问题及公司回复情况 公司就投资者在本次说明会中提出的问题进行了回复： 1、请介绍一下公司目前各个生产基地的情况，如定位、 建成时间、规模、产品、产能、赢利等方面，谢谢！ 尊敬的投资者，您好，感谢您的关注。公司的主要生产 基地具体情况详见公司年度报告及相关投资公告。 2、公司准备以简易程序向特定对象发行股份融资总额不 超过人民币 3 亿元，资金用途 ...